Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://declanfvdq120410.digiblogbox.com/63353823/trelaglutide-exploring-a-new-option-for-chronic-diseases